Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
51,100,303
-
Share change
-
-1,086,276
-
Total reported value
-
$1,647,406,369
-
Price per share
-
$32.24
-
Number of holders
-
156
-
Value change
-
-$35,199,383
-
Number of buys
-
86
-
Number of sells
-
74
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q4 2015
As of 31 Dec 2015,
HAEMONETICS CORP - Common Stock (HAE) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,100,303 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Fund Advisors, PRICE T ROWE ASSOCIATES INC /MD/, Black Creek Investment Management Inc., Neuberger Berman Group LLC, WELLS FARGO & COMPANY/MN, WESTWOOD HOLDINGS GROUP INC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, and BARROW HANLEY MEWHINNEY & STRAUSS LLC.
This page lists
156
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.